Remifentanil injected during analepsia shortens length of postanesthesia care unit stay in patients undergoing laparoscopic surgery for endometrial cancer: a randomized controlled trial | Zendy

Linjia Zhu | Zendy; Sibi Zhang | Zendy; Xiuhong Jiang | Zendy; Yan Ni | Zendy

Open Access

Remifentanil injected during analepsia shortens length of postanesthesia care unit stay in patients undergoing laparoscopic surgery for endometrial cancer: a randomized controlled trial

Author(s) -

Linjia Zhu,

Sibi Zhang,

Xiuhong Jiang,

Yan Ni

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-1146

Subject(s) - pacu , medicine , remifentanil , anesthesia , propofol , adverse effect , bispectral index , laparoscopic surgery , surgery , laparoscopy

To guarantee efficient operating room (OR) activity, tracheal extubation is often performed in the postanesthesia care unit (PACU). Therefore, the ability of PACU to accommodate postoperative patients is crucial. Optimizing extubation management may speed up the turnover of PACU beds. The aim of the present study was to investigate the effect of remifentanil, which is used during analepsia, on the length of PACU stay in patients undergoing laparoscopic surgery for endometrial cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research